ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice
- 26 November 2010
- journal article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 29 (24), 4118-4131
- https://doi.org/10.1038/emboj.2010.292
Abstract
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.Keywords
This publication has 98 references indexed in Scilit:
- Lnk constrains myeloproliferative diseases in miceJCI Insight, 2010
- Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cellsNature Immunology, 2009
- Oxidative Stress in the Regulation of Normal and Neoplastic HematopoiesisAntioxidants and Redox Signaling, 2008
- TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen speciesThe Journal of Experimental Medicine, 2008
- Functional interaction between FOXO3a and ATM regulates DNA damage responseNature, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell HomeostasisCell, 2007
- Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cellsThe EMBO Journal, 2006
- A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life SpanCell, 2006
- Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegansNature, 2003